Ultrasensitive, structural variant-based ctDNA monitoring reliably tracks therapeutic response and predicts progression in metastatic breast cancer, and is a strong independent prognostic marker in ...
India’s cancer crisis is driven by late detection, with most cases diagnosed late. Improving awareness, screening, and timely ...